Helixmith Co. Ltd (084990) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.020x

Based on the latest financial reports, Helixmith Co. Ltd (084990) has a cash flow conversion efficiency ratio of -0.020x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.85 Billion ≈ $-1.93 Million USD) by net assets (₩141.52 Billion ≈ $95.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Helixmith Co. Ltd - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Helixmith Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Helixmith Co. Ltd carry for a breakdown of total debt and financial obligations.

Helixmith Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Helixmith Co. Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Knafaim
TA:KNFM
0.023x
Aniplus Inc
KQ:310200
0.106x
Nuveen California Select Tax Free Income Closed Fund
NYSE:NXC
-0.014x
Wanshih Electronic Co Ltd
TWO:6134
-0.054x
SinoMedia Holding Limited
F:SJY
0.010x
Credit Clear Ltd
AU:CCR
0.052x
Panstar Enterprise Co.Ltd
KQ:054300
0.031x
Great Boulder Resources Ltd
AU:GBR
-0.022x

Annual Cash Flow Conversion Efficiency for Helixmith Co. Ltd (2010–2025)

The table below shows the annual cash flow conversion efficiency of Helixmith Co. Ltd from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see Helixmith Co. Ltd market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩141.52 Billion
≈ $95.91 Million
₩-6.90 Billion
≈ $-4.67 Million
-0.049x +58.59%
2024-12-31 ₩142.04 Billion
≈ $96.26 Million
₩-16.72 Billion
≈ $-11.33 Million
-0.118x +30.11%
2023-12-31 ₩153.72 Billion
≈ $104.18 Million
₩-25.89 Billion
≈ $-17.54 Million
-0.168x +10.38%
2022-12-31 ₩216.80 Billion
≈ $146.92 Million
₩-40.74 Billion
≈ $-27.61 Million
-0.188x -10.96%
2021-12-31 ₩225.35 Billion
≈ $152.72 Million
₩-38.16 Billion
≈ $-25.86 Million
-0.169x +2.54%
2020-12-31 ₩276.30 Billion
≈ $187.25 Million
₩-48.01 Billion
≈ $-32.54 Million
-0.174x +17.25%
2019-12-31 ₩195.57 Billion
≈ $132.53 Million
₩-41.07 Billion
≈ $-27.83 Million
-0.210x -108.92%
2018-12-31 ₩133.87 Billion
≈ $90.72 Million
₩-13.46 Billion
≈ $-9.12 Million
-0.101x -538.11%
2017-12-31 ₩164.45 Billion
≈ $111.45 Million
₩-2.59 Billion
≈ $-1.76 Million
-0.016x -9.76%
2016-12-31 ₩170.93 Billion
≈ $115.84 Million
₩-2.45 Billion
≈ $-1.66 Million
-0.014x -188.31%
2015-12-31 ₩67.20 Billion
≈ $45.54 Million
₩1.09 Billion
≈ $740.06K
0.016x +9598.28%
2013-12-31 ₩66.97 Billion
≈ $45.38 Million
₩11.22 Million
≈ $7.60K
0.000x +100.30%
2012-12-31 ₩64.45 Billion
≈ $43.68 Million
₩-3.58 Billion
≈ $-2.43 Million
-0.056x -26.50%
2011-12-31 ₩49.78 Billion
≈ $33.74 Million
₩-2.19 Billion
≈ $-1.48 Million
-0.044x +12.11%
2010-12-31 ₩52.72 Billion
≈ $35.73 Million
₩-2.64 Billion
≈ $-1.79 Million
-0.050x --

About Helixmith Co. Ltd

KQ:084990 Korea Food & Tobacco
Market Cap
$85.64 Million
₩126.37 Billion KRW
Market Cap Rank
#19817 Global
#1135 in Korea
Share Price
₩7920.00
Change (1 day)
-5.15%
52-Week Range
₩2605.00 - ₩9470.00
All Time High
₩167270.44
About

Helixmith Co., Ltd, a biotechnology company, discovers and develops biopharmaceuticals for human diseases. The company has a pipeline of novel biologics and herbal therapeutics in the areas of cardiovascular disease, cancer, and immune disorder, with clinical studies ongoing in the United States, Korea, and China. Its flagship product is VM202, a DNA-based drug for cardiovascular and neurological… Read more